ArticleEpilepsia open2025
Gingival enlargement following levetiracetam treatment: A clinical case analysis.
Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular Investigation of the Effects of Two Antiepileptic Drugs (Valproic Acid and Levetiracetam) on Alveolar Bone Under Orthodontic Force.Medicina (Kaunas, Lithuania) · 2026Article
- Gingival enlargement following levetiracetam treatment: A clinical case analysis.Epilepsia open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report describes a 21-year-old female with a history of epilepsy, diagnosed at age 17, who developed gingival enlargement after being treated with levetiracetam. Her dosage was titrated to 750 mg twice daily, achieving satisfactory seizure control. Regular neurological evaluations and laboratory tests remained within normal limits for 3 years. However, the patient subsequently reported increased gingival size and a perception that her teeth appeared smaller. Examination confirmed gingival enlargement, with no other medications or underlying conditions contributing to this side effect. Genetic testing did not reveal any predisposition to gingival enlargement. Following a careful review, levetiracetam was tapered, and the patient was transitioned to lamotrigine. Dental evaluation suggested surgical intervention for cosmetic purposes. This case highlights the importance of counseling and monitoring for gingival enlargement as a notable side effect of levetiracetam. PLAIN LANGUAGE SUMMARY: A 21-year-old woman diagnosed with epilepsy at 17 experienced gingival enlargements after being treated with levetiracetam at 750 mg twice daily, which effectively controlled her seizures. While her neurological evaluations remained normal for 3 years, she later reported that her gingiva appeared larger, making her teeth look smaller. Comprehensive investigations, including genetic testing, showed no genetic predisposition to this issue. Following a careful review of her treatment, her levetiracetam dosage was lowered, and she was switched to lamotrigine. A dental evaluation recommended surgery for cosmetic improvement, emphasizing the importance of monitoring for gingival enlargement as a potential side effect of levetiracetam.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.